OR WAIT null SECS
Greenphire's Chief Commercial Officer predicts 2020 will continue the momentum towards greater technology adoption and patient focus.
This past year was a productive one for the clinical trial industry. We saw substantial innovation with technologies that streamline clinical operations and enhance the participant experience. Artificial Intelligence (AI) and patient centricity remained a key industry focus, and real progress was made to shift processes away from siloed and manual efforts into automated workflows.
2020 will continue the momentum towards greater technology adoption and patient focus. Top trends I foresee over the next year include:
Patient convenience initiatives will continue to proliferate in 2020 and beyond. There are multiple aspects to this concept of “convenience” and all will remain top priorities for trial sites and sponsors.
Financial lifecycle management in clinical trials is crucial to study success. Over the past decade, site and patient payments have become automated, improving the sponsor and site relationships and streamlining workflows. In 2020, there will be a greater focus on improving study star-up and feasibility with improved data and automation capabilities, specifically related to site budget and negotiation processes.
Setting a trial budget and negotiating with sites has been a long and arduous process that can start the study off negatively, with delays, added costs and frustration. In 2020, we will begin to see new capabilities introduced to “engineer-out” many of the existing challenges and costly processes, ultimately improving the experience for all stakeholders.
Electronic data capture has long been the standard of processing patient data and submitting it to the proper regulatory authorities. eSource satisfies those same requirements but enables healthcare providers to enter data directly into a smart device, eliminating a step and preventing additional opportunities for human error.
To date, there has been some hesitation in implementing eSource systems, driven by complexities regarding device distribution and support. What is the role of the sponsor? Of the Site? Is BYOD (Bring Your Own Device) the better approach? Security and data privacy has also been a concern. However, I believe that we’ve hit a tipping point where many of these objections have been addressed and there has been sufficient adoption and success, paving the way for others to follow suit. The benefits of eSource systems will prove to be favorable, making this a go-to technology approach over the coming years.
Wayne Baker is the Chief Commercial Officer at Greenphire